Showing results (41-50 of 213) with videos related to

Sort By:
Pageof 22
Non-Coding RNA Research|August 31, 2018
TGF-β1 signaling in kidney disease: From Smads to long non-coding RNAsPatrick Ming-Kuen Tang, Philip Chiu-Tsun Tang, Jeff Yat-Fai Chung, et al.
Frontiers in Cell and Developmental Biology|April 8, 2020
Diverse Role of TGF-β in Kidney DiseaseYue-Yu Gu, Xu-Sheng Liu, Xiao-Ru Huang, et al.
Frontiers in Physiology|May 31, 2021
Transforming Growth Factor-β and Long Non-coding RNA in Renal Inflammation and FibrosisYue-Yu Gu, Jing-Yun Dou, Xiao-Ru Huang, et al.
Future Medicinal Chemistry|April 3, 2020
TGF-β in renal fibrosis: triumphs and challengesYue-Yu Gu, Xu-Sheng Liu, Xiao-Ru Huang, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|April 17, 2025
SARS-CoV-2 nucleocapsid protein induces a Mincle-dependent macrophage inflammatory response in acute kidney injuryRui-Zhi Tan, Wen-Jing Zhao, Jing Gao, et al.
Clinical and Experimental Pharmacology & Physiology|August 19, 2014
Transforming growth factor-β1 mediates psoriasis-like lesions via a Smad3-dependent mechanism in miceYun Zhang, Xiao-Ming Meng, Xiao-Ru Huang, et al.
Molecular Therapy. Methods & Clinical Development|September 21, 2020
Treatment of Hypertensive Heart Disease by Targeting Smad3 Signaling in MiceJinxiu Meng, Yuyan Qin, Junzhe Chen, et al.
Oncotarget|October 17, 2015
Treatment of renal fibrosis by rebalancing TGF-β/Smad signaling with the combination of asiatic acid and naringeninXiao-ming Meng, Yun Zhang, Xiao-Ru Huang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 27, 2014
miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-β/Smad3 signalingYang Zhang, Xiao-Ru Huang, Li-Hua Wei, et al.
Kidney Diseases (Basel, Switzerland)|August 16, 2021
Lysosome Depletion-Triggered Autophagy Impairment in Progressive Kidney InjuryXiao-Cui Chen, Zhi-Hang Li, Chen Yang, et al.
Pageof 22